Table 1 Patient characteristics
|  | all pts. (n = 131) | DCIS pts. (n = 96) | miCa pts. (n = 35) | p value(*) |
|---|---|---|---|---|
mean age [range] | 56 [36–84] | 56 [36–84] | 54 [38–78] | NS |
initial management | Â | Â | Â | Â |
 lumpectomy | 89 (68%) | 68 (71%) | 21 (60%) | NS |
 mastectomy | 42 (32%) | 28 (29%) | 14 (40%) |  |
adjuvant treatment | Â | Â | Â | Â |
 radiotherapy | 89 (68%) | 68 (71%) | 21 (60%) | NS |
 endocrine treatment | 10 (8%) | 1 (1.0%) | 9 (26%) | <  0.0001 |
 cytotoxic treatment | 2 (2%) | 0 (0.0%) | 2 (6%) | 0.03 |
 observation | 39 (30%) | 27 (28%) | 12 (34%) | NS |
 trastuzumab | 1 (1%) | 0 (0%) | 1 (3%) | NS |
 recurrences | 18 (14%) | 14 (14%) | 4 (11%) | NS |
 DFS at 5 years | 94% (n = 124) | 94% (n = 91) | 94% (n = 34) | NS |
 DFS at 10 years | 89% (n = 108) | 88% (n = 78) | 91% (n = 31) |